Q1 2025 Earnings Conference Call May 1, 2025 8:00 AM ETCompany ParticipantsMichaela Pewarski - Vice President, ...

Neurocrine Biosciences, Inc. today announced the release of findings from a new survey conducted by The Harris Poll highlighting the profound negative impact of tardive dyskinesia on patients and ...

What if business leaders approached strategy the way scientists design gene delivery vectors? In biotechnology, precision, iteration and aligned resources are all critical drivers of breakthroughs ...

Growing Biotechnology Demand There is certainly a lot to go at for the prospective new venture given that, according to Cervicorn Consulting, the global biotechnology market size is expected to soar ...

Rishabh Software and S4G Consulting have teamed up to introduce SR360, a business-driven end-to-end Technology service designed to help enterprises modernize their technology without the usual ...

Unity Biotechnology, a Bay Area company that once won high-profile backers and a $700 million valuation for its research into aging, is now laying off every one of its remaining employees.

In the headquarters of a mid-sized pharmaceutical company preparing for its first product launch, a scene once considered ...

MOUNT VERNON, N.Y., April 29, 2025 /PRNewswire/ -- The Business Council of Westchester (BCW) proudly announces The Grandview Consulting ... universities, biotech firms, nonprofits, entrepreneurs ...

Bay Area biotech company Tempest Therapeutics was ... some “key employees” in the laid-off group would likely move to consulting agreements. It’s a drastic move for dire straits.

This will open doors for new advances in medicine, agriculture, and biotechnology by helping scientists design proteins that can multitask more efficiently. “Two structurally identical plant ...

UNITY Biotechnology (UBX) announced that the peer-reviewed journal NEJM Evidence published results from the Phase 2 BEHOLD study of UBX1325 in patients with diabetic macular edema. As reported in ...

CHICAGO--(BUSINESS WIRE)--MAIA Biotechnology, Inc., (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company developing ...